Drug Research
AbbVie, Harvard University Form Research Alliance to Address Emergent...
AbbVie and Harvard University announced a $30 million collaborative research alliance, launching a multi-pronged effort at Harvard Medical School (HMS) to study and develop novel...
Clinical Trials
BMS Provides Update on Phase 3 IDHENTIFY Trial in...
Bristol Myers Squibb announced that the Phase 3 IDHENTIFY study evaluating IDHIFA® (enasidenib) plus best supportive care (BSC) versus conventional care regimens, which include best...
Press Releases
Mitsubishi Tanabe Pharma Launch of VAFSEO,for the treatment of...
Mitsubishi Tanabe Pharma Corporation announced that MTPC is launchingVAFSEO®Tablets 150mg and 300mg (VAFSEO®, vadadustat) which is anoralhypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor in-licensed from Akebia...
Press Releases
Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio for Ion Torrent...
In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease. Today, Thermo...
Drug Research
Catalent Signs Agreement with AstraZeneca to Expand Manufacturing Support...
Catalent, Inc., the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...
Press Releases
PharmaSources.com to Help Propel the Chinese API Export Business...
PharmaSources.com, the vertical B2B portal for the pharmaceutical industry, announces the launch of the virtual session CPhI China Top API Exporters & Products on 24-28...
Press Releases
PharmaSources Launches the Export-Driven Event CPhI & P-MEC China...
PharmaSources, an international B2B trade portal for the pharmaceutical verticals, is launching the virtual event CPhI & P-MEC China E-Trade Season from August to December...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.